Investigational Site Number 250024

Montpellier 34295

0 studies enrolling now · 2 studies all time

What they study most

Cancer, Multiple Sclerosis, Venous Thromboembolism

Studies at this site

• Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients — Completed
• Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy — Completed